Multiplier AI Blog
Know How Data, AI, & Digital Marketing Can Help Pharma & Life Sciences
Competitive Share of Voice in Pharma: How AI Tracks It Across Digital and Field Channels
Competitive share of voice pharma AI tracking starts from a simple observation: in pharma, market share is often treated as the ultimate measure of success because it reflects prescribing behavior, adoption rates, and commercial performance. However, market share is an outcome.
How AI Summarizes Clinical Conference Insights for Pharma Field Teams
AI clinical conference insights in pharma address one of the industry's most persistent operational gaps. Clinical conferences are among the most information-rich events in the pharma industry — they bring together new research, expert opinions, emerging data, and evolving treatment perspectives in one place.
Turning Prescribing Pattern Shifts Into Field Intelligence: A Practical Guide
Every pharma organization has access to prescribing data. It is one of the most valuable assets in commercial operations. It shows what doctors are doing, how treatments are being adopted, and how markets are evolving.
How to Monitor Competitor Brand Launches Before They Happen: An AI Approach
Monitor pharma competitor launch AI strategies exist because, in pharma, a competitor launch is not a surprise event. It is the result of years of clinical development, regulatory work, and commercial preparation. Yet despite this long timeline, many organizations still find themselves reacting rather than preparing.
Pharma Competitive Intelligence in the Age of AI: From Quarterly Reports to Real-Time Signals
Competitive intelligence has always been a critical function in pharma. Understanding what competitors are doing, how markets are shifting, and where opportunities exist has a direct impact on commercial success.
Patient-Centric vs HCP-Centric Omnichannel: Why You Need Both and How They Connect
The False Choice That Limits Most Pharma StrategiesThe debate over patient-centric vs HCP-centric omnichannel pharma engagement has shaped how most companies allocate budgets, build teams, and design campaigns. Some teams emphasize healthcare professionals as the primary audience, while others advocate for a more patient-focused approach.
The Rise of AI-Generated Pharma Content: Compliance, Quality, and What MLR Teams Need to Know
In most pharma organizations today, the biggest constraint is no longer data or distribution. It is content — and this is exactly where AI-generated pharma content is changing the equation. Teams have more channels than ever: email, field engagement, digital platforms, mobile messaging, and virtual interactions are all available, and the ability to reach healthcare professionals has expanded si
Omnichannel HCP Engagement for Specialty Pharma: A Different Set of Rules
Most omnichannel strategies in pharma are built with scale in mind. They assume large HCP bases, broad segmentation, and high-volume outreach across multiple channels. This approach can work reasonably well for primary care therapies where reach and frequency are important.
The Role of WhatsApp and Mobile Messaging in Indian Pharma HCP Engagement
If you look at how pharma engagement has evolved in India over the last decade, one shift stands out clearly. Access to doctors has become more difficult, attention has become more fragmented, and traditional channels are no longer sufficient on their own.
How to Coordinate Field Sales and Digital Campaigns Without Confusing Your HCPs
From inside a pharma organization, engagement often looks structured and intentional. Campaign calendars are defined, field visits are planned, and digital outreach is scheduled across channels. Each team knows what it is doing and why.
Pharma Omnichannel on a Mid-Size Budget: A Practical Playbook for Growth
The myth that omnichannel requires enterprise budgets. There is a common belief in the pharma industry that true omnichannel engagement is only achievable for large organizations with extensive resources.
Why HCPs Still Receive Generic Pharma Communications and How to Fix It
The uncomfortable truth about pharma communication: If you speak honestly with most healthcare professionals, a common frustration emerges. They are not lacking information. They are overwhelmed by it.